By screening the marker genes of early stage EndMT, the marker gene at the early stage was finally identified as ACTA2 with an SMD of 0.87,95% CI (0.23,1.51) for COVID-19 vs. control in 5 GEO datasets following meta-analysis (Figure 5F). This evidence concerns the gene ACTA2 and COVID-19.